IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock Cash Flow
NASDAQ:IOVA - Nasdaq - US4622601007 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -375.36M | -372.18M | -444.04M | -395.89M | -342.25M | |||
| Depreciation Amortization | 33.75M | 33.17M | 21.42M | 9.31M | 3.11M | |||
| Change In Working Capital | -110.89M | -125.38M | -10.00M | -2.89M | 24.55M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 3.26M | 2.83M | 3.48M | N/A | N/A | |||
| Other non cash items | 118.11M | 111.42M | 70.80M | 96.72M | 86.65M | |||
| OPERATING CASH FLOW | -334.39M | -352.98M | -361.82M | -292.76M | -227.94M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -13.11M | -11.07M | -22.29M | -20.43M | -37.57M | |||
| Other Investing Activity | 44.07M | -85.34M | -132.95M | 276.88M | 37.71M | |||
| INVESTING CASH FLOW | 30.96M | -96.41M | -155.24M | 256.46M | 130.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 1.00M | |||
| Stock Issued/Repurchased | 354.20M | 403.52M | 465.75M | 192.80M | 238.27M | |||
| Other Financing Activity | -13.80M | -12.86M | -2.79M | -2.65M | N/A | |||
| FINANCING CASH FLOW | 340.40M | 390.66M | 462.96M | 190.15M | 239.27M | |||
| Exchange Rate Effect | 458.00K | -541.00K | -2.74M | N/A | N/A | |||
| CHANGE IN CASH | 37.43M | -59.27M | -56.84M | 153.85M | 11.46M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -334.39M | -352.98M | -361.82M | -292.76M | -227.94M | |||
| Capital Expenditure | -13.11M | -11.07M | -22.29M | -20.43M | -37.57M | |||
| FREE CASH FLOW | -347.50M | -364.05M | -384.11M | -313.19M | -265.51M | |||
All data in USD